Holen Sie sich die Stockscreener-App
0.8776
0.93%
-0.0123
Schlusskurs vom Vortag:
$0.8899
Offen:
$0.8982
24-Stunden-Volumen:
37,563
Relative Volume:
0.26
Marktkapitalisierung:
$23.39M
Einnahmen:
$2,000
Nettoeinkommen (Verlust:
$-9.12M
KGV:
-2.2543
EPS:
-0.3893
Netto-Cashflow:
$-3.35M
1W Leistung:
+3.74%
1M Leistung:
-23.33%
6M Leistung:
-37.02%
1J Leistung:
-72.53%
1-Tages-Spanne:
$0.8651
$0.9098
1-Wochen-Bereich:
$0.8208
$0.96
52-Wochen-Spanne:
$0.8208
$3.40
Abvc Biopharma Inc Stock (ABVC) Company Profile
Firmenname
Abvc Biopharma Inc
Sektor
Branche
Telefon
510-668-0881
Adresse
44370 OLD WARM SPRINGS BLVD., FREMONT
Compare ABVC vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABVC
Abvc Biopharma Inc
|
0.8776 | 23.72M | 2,000 | -9.12M | -3.35M | -0.3893 |
VRTX
Vertex Pharmaceuticals Inc
|
550.55 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
829.47 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,014.42 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
139.20 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.08 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abvc Biopharma Inc Aktie (ABVC) Neueste Nachrichten
ABVC (ABVC) Earnings Report: The Latest Financial Metrics Are Now Available in the Latest Session; Trading Response: Shares Finish 8.39% Up in the Latest SessionNet Income Trends - vinanet.vn
ABVC BioPharma (ABVC) Slides 5.56% to $0.85 as Micro-Cap Biotech Faces Selling PressureGap Fill Strategy - vinanet.vn
ABVC Q1 2025 Earnings: Net Loss of -$0.06 Per Share, Stock Slips 6.2%Earnings Growth Forecast - vinanet.vn
ABVC BioPharma (ABVC) Slips 6.2% to $0.90 as Selling Pressure Builds Near Key SupportInstitutional Buy Signals - Vinanet
ABVC BioPharma (ABVC) Declines 6.2% to $0.90, Testing Key SupportVolatility Smile - vinanet.vn
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
ABVC BioPharma (ABVC) plans new equity plan and up to 6.6M-share land deal - Stock Titan
ABVC BIOPHARMA, INC. Q2 2026: Revenue $0 EPS $(0.03) — 10-Q Summary - TradingView
ABVC BioPharma (ABVC) flags going concern risk after Q2 2026 cash drain - Stock Titan
ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21 - TradingView
Form 8K ABVC Biopharma Inc For: 12 August By Investing.com - Investing.com Nigeria
ABVC BioPharma (ABVC) Financials 2026Income Statement and Balance Sheet - MarketBeat
ABVC Biopharma Inc (ABVC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ABVC Q1 2025 Earnings: Net Loss of $0.06 Per Share as Clinical-Stage Biotech Remains Pre-RevenuePeak Earnings Alert - dars.gov.et
ABVC Biopharma Inc (ABVC) Stock News Today - TradingKey
ABVC BioPharma Delays Planned BioKey Share Distribution - TipRanks
ABVC postpones BioKey share distribution; ratio, record date unchanged - TradingView
ABVC BioPharma, Inc.Distribution Option Symbol: ABVC New Symbol: ABVC1 * * * Ex-Date Revised * * *moomoo - Moomoo
ABVC BioPharma (ABVC) Slips 6.48% to $1.01 as Stock Tests Key SupportWeekly Profile - dars.gov.et
ABVC BioPharma (ABVC) to vote on 2026 equity plan and Taiwan land-share issuance - Stock Titan
ABVC Biopharma Inc (ABVC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ABVC Biopharma Inc (ABVC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ABVC Biopharma Inc (ABVC) Cash Flow - TradingKey
ABVC Biopharma Inc (ABVC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ABVC Biopharma Inc (ABVC) Institutional Confidence - TradingKey
ABVC Biopharma Inc (ABVC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ABVC Biopharma Inc (ABVC) Balance Sheet - TradingKey
ABVC|ABVC Biopharma Inc|Price:1.030|Chg%:-0.120 - TradingKey
ABVC Biopharma Inc (ABVC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ABVC Biopharma Inc (ABVC) Valuation: PE, PB & Fair Value Analysis - TradingKey
ABVC Biopharma Inc (ABVC) Income Statement - TradingKey
ABVC BioPharma, Inc. Revenue Breakdown – NASDAQ:ABVC - TradingView
ABVC BioPharma Sheds 3.33% as Shares Test Key Support at $1.10Wyckoff Spring - dars.gov.et
ABVC BioPharma Inc. (ABVC) Gains 3.3% as Shares Test Key ResistanceGEX Level - dars.gov.et
ABVC BioPharma Edges Lower, Trading Near Key Support at $1.27Andrews Pitchfork - dars.gov.et
MSN Money - MSN
ABVC BioPharma (ABVC) Rallies Over 6%, Testing Key Resistance at $2.12Volume Oscillator - dars.gov.et
ABVC BioPharma (ABVC) replaces auditor and reiterates going-concern language - Stock Titan
Price to sales forward of ABVC BioPharma, Inc. – NASDAQ:ABVC - TradingView
Enterprise value to EBITDA forward of ABVC BioPharma, Inc. – NASDAQ:ABVC - TradingView
Price to book forward of ABVC BioPharma, Inc. – NASDAQ:ABVC - TradingView
ABVC Should I Buy - Intellectia AI
ABVC BioPharma, Inc. Actuals & Estimates (NASDAQ:ABVC) - TradingView
ABVC Q1 2025 Earnings: EPS of -0.06 Reflects Ongoing R&D Investment; Stock Gains 2.82%Earnings Yield Spread - dars.gov.et
ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc. Through Dividend Distribution of BioKey Shares to ABVC Shareholders - 富途牛牛
ABVC BioPharma Inc. (ABVC) Q1 2025 Earnings: Net Loss of $0.06 Per Share as Stock Rises 1.53% Amid No Reported RevenueForward Guidance Trends - dars.gov.et
ABVC BioPharma to Spin Off BioKey Subsidiary via Dividend Distribution to Shareholders - MEXC
ABVC Q1 2025 Earnings: Loss Per Share of -$0.06 as Clinical Pipeline ProgressesBook Value Growth - dars.gov.et
ABVC Biopharma Inc (ABVC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ABVC BioPharma Inc. (ABVC) Surges 7.39% — Testing Key Resistance at $1.34Relative Volume - newsline.com
ABVC Q1 2025 Earnings: Net Loss of -$0.06 Per Share Reflects Pre‑Revenue Development Stage; Stock Declines 9.2% - newsline.com
Finanzdaten der Abvc Biopharma Inc-Aktie (ABVC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.14%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):